Autologous stem cell transplantation for enteropathy-associated T-cell lymphoma: A retrospective study by the EBMT

Blood

Volumn 121, Issue 13, 2013, Pages 2529-2532

  Jantunen, Esa ^a   Boumendil, Ariane ^b   Finel, Herve ^b   Luan, Jian Jian ^b   Johnson, Peter ^c   Rambaldi, Alessandro ^d   Haynes, Andrew ^e   Duchosal, Michel A ^f   Bethge, Wolfgang ^g   Biron, Pierre ^h   Carlson, Kristina ⁱ   Craddock, Charles ^j   Rudin, Claudius ^k   Finke, Jurgen ^l   Salles, Gilles ^m   Kroschinsky, Frank ⁿ   Sureda, Anna ^o   Dreger, Peter ^p  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b EBMT Lymphoma Working Party   (France)

^c WESTERN GENERAL HOSPITAL   (United Kingdom)

^d Hospital Papa Giovanni XXIII   (Italy)

^e NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^f LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^g UNIVERSITY OF TÜBINGEN   (Germany)

^h CENTRE LÉON BÉRARD   (France)

ⁱ UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^j QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^k ROYAL DEVON AND EXETER HOSPITAL   (United Kingdom)

^l UNIVERSITY OF FREIBURG   (Germany)

^m UNIVERSITÉ LYON 1   (France)

ⁿ UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^o ADDENBROOKE S HOSPITAL   (United Kingdom)

^p UNIVERSITY OF HEIDELBERG   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; CYTOSINE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; IFOSFAMIDE; MELPHALAN; METHOTREXATE; PREDNISONE; VINCRISTINE; VINDESINE;

ADULT; AGED; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CELIAC DISEASE; CLINICAL ARTICLE; DISEASE CONTROL; ENTEROPATHY ASSOCIATED T CELL LYMPHOMA; FEMALE; FOLLOW UP; HUMAN; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; WHOLE BODY RADIATION; AUTOTRANSPLANTATION; EVALUATION; GERMANY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MEDICAL SOCIETY; METHODOLOGY; MIDDLE AGED; MORTALITY; ONCOLOGY; ORGANIZATION AND MANAGEMENT; SURVIVAL; TREATMENT OUTCOME;

ADULT; AGED; ENTEROPATHY-ASSOCIATED T-CELL LYMPHOMA; FEMALE; GERMANY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MEDICAL ONCOLOGY; MIDDLE AGED; RETROSPECTIVE STUDIES; SOCIETIES, MEDICAL; SURVIVAL ANALYSIS; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 84878415224     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-11-466839     Document Type: Article

References (14)

1. Delabie J, Holte H, Vose JM, et al. Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project. Blood. 2011; 118(1):148-155.
2. Gale J, Simmonds PD, Mead GM, et al. Enteropathy-type intestinal T-cell lymphoma: clinical features and treatment of 31 patients in a single center. J Clin Oncol. 2000;18(4):795-803.
3. Daum S, Ullrich R, Heise W, et al. Intestinal non-Hodgkin’s lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal non-Hodgkin’s Lymphoma. J Clin Oncol. 2003;21(14):2740-2746.
4. Al-Toma A, Verbeek WH, Hadithi M, et al. Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience. Gut. 2007; 56(10):1373-1378.
5. Di Sabatino A, Biagi F, Gobbi PG, et al. How I treat enteropathy-associated T-cell lymphoma. Blood. 2012;119(11):2458-2468.
6. Jantunen E, Juvonen E, Wiklund T, et al. High-dose therapy supported by autologous stem cell transplantation in patients with enteropathy-associated T-cell lymphoma. Leuk Lymphoma. 2003;44(12):2163-2164.
7. Bishton MJ, Haynes AP. Combination chemotherapy followed by autologous stem cell transplant for enteropathy-associated T cell lymphoma. Br J Haematol. 2007;136(1):111-113.
8. Al-Toma A, Verbeek WH, Visser OJ, et al. Disappointing outcome of autologous stem cell transplantation for enteropathy-associated T-cell lymphoma. Dig Liver Dis. 2007;39(7):634-641.
9. Sieniawski M, Angamuthu N, Boyd K, et al. Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation. Blood. 2010;115(18):3664-3670.
10. d’Amore F, Relander T, Lauritzsen GF, et al. Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01. J Clin Oncol. 2012;30(25):3093-3099.
11. Kyriakou C, Canals C, Goldstone A, et al; Outcome-Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. High-dose therapy and autologous stem-cell transplantation in angioimmunoblastic lymphoma: complete remission at transplantation is the major determinant of Outcome-Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. J Clin Oncol. 2008;26(2): 218-224.
12. Chen AI, McMillan A, Negrin RS, et al. Long-term results of autologous hematopoietic cell transplantation for peripheral T cell lymphoma: the Stanford experience. Biol Blood Marrow Transplant. 2008;14(7):741-747.
13. Nickelsen M, Ziepert M, Zeynalova S, et al. High-dose CHOP plus etoposide (MegaCHOEP) in T-cell lymphoma: a comparative analysis of patients treated within trials of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL). Ann Oncol. 2009;20(12): 1977-1984.
14. Reimer P, Rüdiger T, Geissinger E, et al. Autologous stem-cell transplantation as first-line therapy in peripheral T-cell lymphomas: results of a prospective multicenter study. J Clin Oncol. 2009;27(1):106-113.